Organicell Regenerative Medicine, Inc.
OCEL · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,705 | -$6,987 | -$8,897 | -$12,757 |
| Dep. & Amort. | $74 | $486 | $333 | $53 |
| Deferred Tax | $0 | -$62 | $0 | -$7,700 |
| Stock-Based Comp. | $3,853 | $3,209 | $3,917 | $8,652 |
| Change in WC | $0 | $788 | $1,394 | $1,442 |
| Other Non-Cash | -$672 | $368 | $87 | $7,700 |
| Operating Cash Flow | -$1,450 | -$2,197 | -$3,166 | -$2,609 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$25 | -$825 | -$496 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$100 | $0 | $0 |
| Inv. Sales/Matur. | $0 | -$741 | $0 | $0 |
| Other Inv. Act. | -$45 | $741 | $0 | $0 |
| Investing Cash Flow | -$45 | $616 | -$825 | -$496 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $500 | $100 | $7,270 | $2,707 |
| Stock Repurch. | $0 | -$500 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $396 | -$415 | $7,635 | $2,623 |
| Financing Cash Flow | $396 | -$415 | $7,635 | $2,623 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,099 | -$1,997 | $3,645 | -$482 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,756 | $3,753 | $109 | $591 |
| End Cash | $657 | $1,756 | $3,753 | $109 |
| Free Cash Flow | -$1,450 | -$2,223 | -$3,991 | -$3,105 |